PHK
ABBV icon

Point72 Hong Kong’s AbbVie ABBV Stock Holding History

Point72 Hong Kong’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-120,836
Closed -$22.4M – 431
2025
Q2 		$22.4M Buy
+120,836
New +$22.5M 1.45% 15
2024
Q1 		– Sell
-90,858
Closed -$14.1M – 518
2023
Q4 		$14.1M Buy
+90,858
New +$13.2M 0.84% 20
2022
Q3 		– Sell
-12,293
Closed -$1.76M – 1876
2022
Q2 		$1.88M Sell
12,293
-41,184
-77% -$6.29M 0.07% 361
2022
Q1 		$8.67M Buy
53,477
+6,271
+13% +$911K 0.3% 59
2021
Q4 		$6.39M Sell
47,206
-41,420
-47% -$4.89M 0.22% 84
2021
Q3 		$9.56M Buy
+88,626
New +$10.1M 0.31% 35
2021
Q2 		– Sell
-50,965
Closed -$5.74M – 1866
2021
Q1 		$5.51M Sell
50,965
-15,584
-23% -$1.67M 0.19% 104
2020
Q4 		$7.13M Buy
+66,549
New +$6.4M 0.32% 37
2020
Q1 		– Sell
-6,491
Closed -$575K – 898
2019
Q4 		$575K Buy
+6,491
New +$539K 0.14% 115
2018
Q4 		– Sell
-6,762
Closed -$640K – 857
2018
Q3 		$640K Buy
+6,762
New +$641K 0.22% 61
2018
Q2 		– Sell
-4,661
Closed -$441K – 869
2018
Q1 		$441K Buy
4,661
+4,653
+58,163% +$511K 0.23% 55
2017
Q4 		$1K Sell
8
-1,687
-100% -$159K ﹤0.01% 729
2017
Q3 		$151K Buy
1,695
+165
+11% +$12.6K 0.11% 78
2017
Q2 		$111K Buy
1,530
+805
+111% +$54.1K 0.12% 92
2017
Q1 		$47K Buy
+725
New +$45.6K 0.06% 251
2015
Q1 		– Sell
-4,319
Closed -$283K – 253
2014
Q4 		$283K Buy
+4,319
New +$272K 0.28% 98

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Hong Kong's ABBV Position: Q3 2025 in Review

Point72 Hong Kong sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 120,836 shares — an estimated $22.4M sold.

Point72 Hong Kong first reported a position in ABBV in Q4 2014 and held it in 16 quarters. The position peaked at $22.4M in Q2 2025. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Point72 Hong Kong reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 120,836 AbbVie shares in Q3 2025, an estimated $22.4M.
  • Point72 Hong Kong first reported a position in AbbVie in Q4 2014 and held it in 16 quarters.
  • Point72 Hong Kong's AbbVie position peaked at $22.4M in Q2 2025.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.